Chemours Company (The)

Valuation Analysis

About the Company

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that delivers whiteness, brightness, opacity, durability, efficiency, and protection in applications, including architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building ma

Chemours Company (The) Stock at a Glance

Chemours Company (The) (CC) is currently trading at $22.00 with a market capitalization of $3.3B. The 52-week range spans from $10.14 to $28.67; the current price is 23.3% below the yearly high. Year-over-year revenue growth stands at +1.0%.

💰 Dividend

Chemours Company (The) pays an annual dividend of $0.35 per share, representing a yield of 1.59%. The payout ratio stands at 555.56%. The elevated payout ratio reflects a mature dividend policy.

📊 Analyst Rating

9 analysts rate Chemours Company (The) (CC) on consensus: Buy. The average price target is $26.33, implying +19.7% from the current price. Analyst price targets range from $21.00 to $30.00.

Chemours Company (The): The Investment Case in Detail

Chemours Company (The) (CC) operates in the Basic Materials — specifically Specialty Chemicals — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Wall Street consensus sits at Buy with an average price target implying roughly 19.7% upside from current levels — analyst sentiment is firmly constructive.

The Bear Case

Revenue growth has slowed to just 1%, which is below nominal GDP — the business is no longer outgrowing the broader economy. Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders. The debt-to-equity ratio of 2033.8% is elevated, meaning the company relies heavily on creditors — refinancing terms will become more important than operational performance in the next economic downturn.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price shows short-term weakness (below 50d MA) but is still in a longer-term uptrend (above 200d MA).

Risk Profile

The data points to market-like volatility, elevated short interest (8.68%), higher leverage relative to equity.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Chemours Company (The)?

Compare top-rated brokers — low fees, trusted providers, fully regulated.